Technical Analysis for TOCA - Tocagen Inc.

Grade Last Price % Change Price Change
grade F 8.875 3.68% 0.32
TOCA closed up 0.71 percent on Thursday, January 17, 2019, on 42 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical TOCA trend table...

Date Alert Name Type % Chg
Jan 17 20 DMA Support Bullish 3.68%
Jan 17 Wide Bands Range Expansion 3.68%
Jan 16 Outside Day Range Expansion 4.41%
Jan 16 Wide Bands Range Expansion 4.41%
Jan 15 Wide Bands Range Expansion -0.50%
Jan 14 Wide Bands Range Expansion 2.25%
Jan 14 Overbought Stochastic Strength 2.25%
Jan 14 Down 3 Days in a Row Weakness 2.25%
Jan 11 Stochastic Sell Signal Bearish -4.26%
Jan 11 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -4.26%

Older signals for TOCA ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Tocagen Inc. (Tocagen) is a clinical-stage, cancer-selective gene therapy company. The Company is focused on developing product candidates designed to activate a patient’s immune system against their own cancer. Its cancer-selective gene therapy platform is built on retroviral replicating vectors (RRVs), which are designed to selectively deliver therapeutic genes into the deoxyribonucleic acid (DNA) of cancer cells. Its lead product candidates are vocimagene amiretrorepvec (Toca 511) and flucytosine extended release (Toca FC). Toca 511 is an investigational injectable retroviral replicating vector (RRV) that encodes a prodrug activator enzyme, cytosine deaminase (CD). Toca FC is an investigational extended-release version of 5-fluorocytosine (5-FC), a prodrug that is inactive as an anti-cancer drug. As of February, 2017, Tocagen has completed enrollment of the Phase II portion with 187 patients.
Is TOCA a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 15.8
52 Week Low 6.47
Average Volume 275,743
200-Day Moving Average 10.3658
50-Day Moving Average 10.4691
20-Day Moving Average 8.409
10-Day Moving Average 9.021
Average True Range 0.7561
ADX 15.33
+DI 16.9961
-DI 21.9129
Chandelier Exit (Long, 3 ATRs ) 7.601699999999999
Chandelier Exit (Short, 3 ATRs ) 8.7383
Upper Bollinger Band 9.9526
Lower Bollinger Band 6.8654
Percent B (%b) 0.55
BandWidth 36.713046
MACD Line -0.4004
MACD Signal Line -0.533
MACD Histogram 0.1327
Fundamentals Value
Market Cap 169.57 Million
Num Shares 19.8 Million
EPS -6.18
Price-to-Earnings (P/E) Ratio -1.39
Price-to-Sales 4252.02
Price-to-Book 2.06
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 9.24
Resistance 3 (R3) 9.26 9.05 9.12
Resistance 2 (R2) 9.05 8.88 9.04 9.08
Resistance 1 (R1) 8.81 8.78 8.93 8.79 9.05
Pivot Point 8.60 8.60 8.67 8.59 8.60
Support 1 (S1) 8.36 8.43 8.48 8.34 8.07
Support 2 (S2) 8.15 8.33 8.14 8.04
Support 3 (S3) 7.91 8.15 8.00
Support 4 (S4) 7.89